目的：制备氯雷他定片并建立其质量控制方法。
OBJECTIVE: to preparation loratadine tablets and to establish a methods of quality for it.
目的比较咪唑斯汀缓释片与氯雷他定片治疗荨麻疹的有效性与安全性。
Efficacy and Safety of Mizolastine Sustained Release Tablets Comparison with Loratadine Tablets in Patients with Urticaria;
结果盐酸氮革斯汀片和氯雷他定片治疗变应性鼻炎的有效率分别为87.93%，82.54%；药物不良反应发生率分别为8.62%，14.06%。
Results the total effective rate was 87.93% for azelastine group and 82.54% for loratadine group, and the adverse event rate was 8.62% and 14.06%, respectively.
结果盐酸氮革斯汀片和氯雷他定片治疗变应性鼻炎的有效率分别为87.93%，82.54%；药物不良反应发生率分别为8.62%，14.06%。
Results the total effective rate was 87.93% for azelastine group and 82.54% for loratadine group, and the adverse event rate was 8.62% and 14.06%, respectively.
应用推荐